IHE vs PJP: Key ETF Metrics Include Expense Ratios and Dividends
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowThe iShares U.S. Pharmaceuticals ETF (IHE) has an expense ratio of 0.38% and a dividend yield of 1.62%, while the Invesco Pharmaceuticals ETF (PJP) has a higher expense ratio of 0.57% and a dividend yield of 0.96%. IHE holds 56 positions, heavily concentrated in Eli Lilly (NYSE:LLY) at 24.2% and Johnson & Johnson (NYSE:JNJ) at 20.3%. In contrast, PJP features 29 companies with Eli Lilly at 5.4%. Investors' choice between IHE and PJP hinges on their comfort with company-specific risks within the pharmaceutical sector.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Johnson & Johnson (JNJ)
Johnson & Johnson is a healthcare giant spanning pharmaceuticals and medical devices, known for its deep drug pipeline.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier JNJ news
- PEP and JNJ Dividends Required for California's $100,600 Income
- Portfolio Needs $400K to Replace $40K Income at 10% Yield
- BMY vs JNJ: Healthcare Revenue Comparison for 2025
- BMY and JNJ Financials: 2025 Revenue Numbers Declared
- PFE and JNJ Annual Dividend Income of $3,540 for Investors
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
